Skip to content
DIVINHEALSimplifying Global Wellbeing
HOME
TREATMENTS
HOSPITALS

Retinal Detachment Repair

5K+ International Patients Treated

40+ Source Countries Served

500+ Accredited Partner Hospitals

98% Patient Satisfaction

80% Average Savings vs USA

10K+ Doctors

NABH, JCI Accredited Hospitals

Free Treatment Plan

Free Consultation with Doctor

5+ Destinations Covered

About Retinal Detachment Repair

Sources and Guidelines Referenced

This clinical guide incorporates evidence-based recommendations and clinical consensus protocols from major international governing bodies in vitreoretinal surgery and ophthalmology: American Academy of Ophthalmology (AAO) Preferred Practice Pattern for Rhegmatogenous Retinal Detachment (2020/2024 update); Royal College of Ophthalmologists (RCOphth) Retinal Detachment Commissioning Guidelines (2021); European Society of Retina Specialists (EURETINA) Guidelines for Management of Rhegmatogenous Retinal Detachment (2021); and landmark randomized controlled trials including the Pneumatic Retinopexy versus Vitrectomy for Retinal Detachment (PIVOT) Trial (Hillier et al., Ophthalmology, 2019) and the Scleral Buckling versus Primary Vitrectomy in Rhegmatogenous Retinal Detachment (SPR) Study (Feltgen et al., Ophthalmology, 2008).

Retinal Detachment Repair: A Comprehensive Patient Guide

1. Definition and Medical Identity

Retinal detachment repair is a emergency or urgent vitreoretinal surgical procedure performed to reattach the light-sensitive layer of tissue at the back of the eye (the neurosensory retina) to its underlying nourishing vascular support layer, the retinal pigment epithelium. The primary clinical objective is to restore tissue integrity, halt peripheral vision collapse, and preserve central sight.

2. The Underlying Condition or Need

Retinal detachment repair is required when fluid accumulates beneath the neurosensory retina, detaching it from the outer globe wall. Without surgical repair, physical separation deprives photoreceptor cells of essential oxygen and metabolic nutrients delivered by the underlying choroid blood vessels. Left untreated, retinal detachment leads to progressive cellular necrosis, permanent visual field loss, and total blindness in the affected eye (American Academy of Ophthalmology [AAO] Preferred Practice Pattern, 2020).

Patients experiencing an acute detachment typically present with sudden-onset photopsia (flashes of light caused by mechanical stimulation of the retina), a rapid shower of floaters (dark spots or web-like opacities representing blood or pigment cells in the vitreous cavity), and a expanding scotoma (a dark curtain or shadow falling across the field of vision). The natural trajectory of untreated rhegmatogenous retinal detachment is complete involvement of the retina and irreversible vision loss, often complicated by chronic intraocular inflammation and globe atrophy (phthisis bulbi).

3. How the Treatment Works — Mechanism

Retinal detachment repair restores normal anatomy through a three-part mechanical mechanism: relieving vitreous traction, evacuating subretinal fluid, and creating a permanent scar around retinal breaks. Micro-incision surgical tools or external bands relieve the mechanical pulling forces exerted by the vitreous humor (the clear gel filling the eye) that created the original break.

Once traction is neutralized and subretinal fluid is removed, the surgeon applies retinopexy—controlled thermal or cold injury delivered via laser photocoagulation or cryopexy (cold probe application). This treatment stimulates an inflammatory response that forms a permanent chorioretinal adhesion (scar tissue) surrounding the retinal break over 7 to 14 days. To hold the retina firmly against the wall of the eye during scar maturation, an internal tamponade agent (such as an expandable gas bubble or silicone oil) or an external band is applied.

4. Types and Variations

There are three primary surgical modalities utilized for retinal detachment repair, selected based on the number, size, and anatomical location of the retinal breaks, as well as patient age and lens status (phakic vs. pseudophakic):

Pneumatic Retinopexy (PR): An office-based procedure involving the intraocular injection of a small expandable gas bubble (such as SF6 or C3F8) into the vitreous cavity, followed by laser photocoagulation or cryopexy. The patient must maintain precise head positioning so the buoyant gas bubble presses directly against the superior retinal tear.

Scleral Buckling (SB): An external surgical technique where a flexible silicone band, sponge, or tire is micro-sutured onto the sclera (the white outer coat of the eye). The band indents the sclera inward toward the center of the eye, relieving vitreous traction and closing the retinal break from the outside without entering the vitreous cavity.

Pars Plana Vitrectomy (PPV): A microsurgical internal procedure performed through tiny trocars placed in the pars plana (the safe transition zone of the sclera). Micro-cutters remove the gel-like vitreous body, evacuate fluid beneath the retina, apply internal laser photocoagulation around breaks, and fill the eye with an internal gas or silicone oil tamponade.

Surgical VariationPrimary IndicationSurgical SettingTamponade MethodInvasiveness
Pneumatic RetinopexySingle superior break, mild/uncomplicated detachmentOutpatient / ClinicIntraocular Gas BubbleMinimally Invasive
Scleral BucklingYoung phakic patients, inferior breaks, dialysesOperating RoomExternal Silicone BandModerately Invasive (External)
Pars Plana VitrectomyComplex detachments, vitreous hemorrhage, PVR, posterior breaksOperating RoomIntraocular Gas or Silicone OilMicrosurgical (Internal)
Combined PPV / SBSevere proliferative vitreoretinopathy, giant retinal tearsOperating RoomGas/Oil Tamponade + Scleral BandHigh Complexity Surgical

5. Who the Treatment Is For — Indications

Retinal detachment repair is indicated immediately upon diagnosis of acute rhegmatogenous retinal detachment (RRD) or progressive tractional retinal detachment (TRD) involving or threatening the macula. Clinical urgency is stratified by macular status: macula-on detachments (where central vision remains intact) represent surgical emergencies that require intervention within 24 hours to prevent detachment of the central retina (EURETINA Guidelines, 2021). Macula-off detachments (where central vision is already lost) are treated urgently within 72 hours, as delay beyond 7 to 10 days significantly diminishes visual recovery potential.

Diagnostic workup requires wide-field fundus photography, binocular indirect ophthalmoscopy with scleral depression, and optical coherence tomography (OCT). In eyes with dense media opacities, such as severe vitreous hemorrhage or dense cataracts, B-scan ultrasonography is essential to map the extent and height of the retinal detachment.

6. Who the Treatment Is NOT For — Contraindications

Absolute contraindications to primary surgical repair are rare due to the sight-threatening nature of retinal detachment, but include an eye with no potential for visual restoration (no light perception vision present for extended periods with proven nerve atrophy) or terminal systemic instability where general or monitored anesthesia poses an immediate threat to life.

Relative contraindications for specific sub-types exist: Pneumatic Retinopexy is contraindicated in eyes with inferior retinal breaks (located between 4 o'clock and 8 o'clock positions), multiple breaks scattered over multiple quadrants, severe proliferative vitreoretinopathy (PVR grade C), or in patients unable to maintain strict head positioning. Scleral buckling is relatively contraindicated in severely thinned sclera (staphyloma) due to increased risk of globe perforation. Silicone oil tamponade is avoided in patients unable to return for a secondary surgical procedure for oil removal, unless permanent tamponade is clinically indicated.

7. Alternatives and Clinical Comparison

For fully established rhegmatogenous retinal detachment, medical therapy or observation is ineffective; surgical repair is mandatory. However, in precursor conditions such as acute symptomatic retinal tears or lattice degeneration without detachment, non-surgical outpatient barrier laser photocoagulation or cryopexy can prevent progression to detachment in over 95% of cases (AAO PPP, 2020).

Treatment OptionMechanismPrimary AdvantageKey Limitation / Trade-Off
Retinal Detachment Repair (PPV/SB)Reattaches detached retina, seals breaks, relieves tractionDefinitive anatomical restoration for established detachmentRequires surgical recovery, potential cataract acceleration
Prophylactic Laser BarrierThermal scar surrounds isolated, non-detached retinal tearIn-office, quick, preserves existing baseline visionIneffective if subretinal fluid has already spread extensively
Observation / Medical ManagementNo surgical intervention; managed with anti-inflammatory drugsNon-invasive; reserved for exudative detachments onlyCatastrophic vision loss if applied to rhegmatogenous detachment

8. Pre-Treatment Phase

The pre-treatment phase focuses on rapid ophthalmic assessment, medical risk stratification, and patient preparation. During consultation, the vitreoretinal surgeon conducts indirect ophthalmoscopy to map all retinal tears and evaluate the risk of proliferative vitreoretinopathy (PVR)—an exaggerated scar tissue reaction inside the eye. The visual status of the contralateral eye is carefully evaluated, as bilateral peripheral vitreoretinal degenerations occur in up to 15% of patients (RCOphth Guidelines, 2021).

Patient preparation involves reviewing medications. Systemic antiplatelet or anticoagulant drugs are evaluated; however, current standard of care for micro-incision vitrectomy allows many blood thinners to be safely continued to prevent systemic cardiovascular events, as intraocular bleeding rates with 25-gauge or 27-gauge instrumentation are extremely low (Mason et al., Retina, 2019). Pre-operative fasting for 6 hours is mandated for patients undergoing monitored anesthesia care (MAC) or general anesthesia. Special planning is arranged for post-operative equipment rentals, such as specialized face-down positioning chairs and head supports.

9. The Procedure — Step-by-Step Clinical Detail

Pars Plana Vitrectomy (PPV) combined with retinopexy represents the most common contemporary surgical technique for retinal detachment repair. The procedure unfolds across standardized chronological phases:

Phase 1: Anesthesia and Surgical Access

The procedure is typically performed in an outpatient surgical facility. Local anesthesia is established via a retrobulbar or peribulbar block combined with intravenous conscious sedation, ensuring total ocular anesthesia and akinesia (inability to move the eye). The surgeon inserts three valved micro-trocars (23-, 25-, or 27-gauge) through the pars plana into the vitreous cavity. One port supplies continuous balanced salt solution to maintain intraocular pressure, the second holds a high-intensity fiber-optic light pipe, and the third accepts working instruments.

Phase 2: Vitrectomy and Traction Relief

Using a pneumatic micro-cutter operating at 5,000 to 10,000 cuts per minute, the surgeon systematically removes the central and peripheral vitreous gel. Mechanical traction exerted by the vitreous gel on all retinal breaks is meticulously trimmed away. If epiretinal membranes or proliferative scar tissue are present on the retinal surface, they are carefully peeled using micro-forceps.

Phase 3: Subretinal Fluid Drainage and Reattachment

To flatten the detached retina, the surgeon performs an air-fluid exchange. Air is pumped into the vitreous cavity while fluid is aspirated through the retinal break using a soft-tipped cannula. Alternatively, heavy liquid (perfluorocarbon liquid, PFCL) is instilled into the eye, acting as a temporary liquid tool that mechanically rolls subretinal fluid forward and out through the break, flattening the retina against the back wall.

Phase 4: Retinopexy (Laser Photocoagulation)

With the retina re-flattened, an intraocular endo-laser probe delivers controlled laser energy to create three to four concentric rows of micro-burns around every retinal break and any vulnerable peripheral retinal degenerations. These laser burns form permanent scar tissue over 10 to 14 days, sealing the break off from the vitreous cavity.

Phase 5: Intraocular Tamponade and Closure

The air or heavy liquid inside the eye is exchanged for a long-acting intraocular gas tamponade (such as sulfur hexafluoride [SF6] or perfluoropropane [C3F8]) or silicone oil. Gas bubbles gradually reabsorb naturally, while silicone oil remains indefinitely until surgically removed months later. The micro-trocars are removed; modern self-sealing scleral incisions rarely require sutures.

10. Immediate Post-Procedure Period

In the first 24 to 48 hours following surgery, an eye patch and protective shield remain over the operated eye. Discharge criteria require stable intraocular pressure, absence of severe nausea or uncontrolled pain, and clear written comprehension of post-operative head positioning requirements. Mild to moderate deep ocular aching and surface foreign-body sensation are normal, managed with oral acetaminophen. Sudden, severe, throbbed pain accompanied by nausea signals an acute spike in intraocular pressure (glaucoma crisis) and requires urgent clinical evaluation.

Antibiotic and corticosteroid eye drops are initiated on post-operative day one to prevent endophthalmitis and suppress intraocular inflammation. If an intraocular gas bubble was placed, the patient must adhere strictly to prescribed head positioning (such as face-down positioning for 16 to 20 hours per day) to maintain continuous physical pressure between the gas bubble and the treated retinal breaks.

11. Recovery — Short and Long Term

Visual and functional recovery follows a distinct timeline dictated by macular status prior to surgery and the type of intraocular tamponade used:

Weeks 1–2: Vision in the surgical eye is extremely blurry—often limited to seeing hand motions—due to the refractive index of the internal gas bubble. Patients must maintain assigned head positioning. Air travel, travel to high elevations (>2,000 feet), and nitrous oxide anesthesia are strictly forbidden, as atmospheric pressure drops cause internal gas bubbles to expand rapidly, causing high intraocular pressure and central retinal artery occlusion.

Weeks 3–8: Short-acting gas bubbles (SF6) reabsorb in 2 to 3 weeks, while long-acting gases (C3F8) require 6 to 8 weeks. As the gas bubble shrinks, patients observe a line in their vision, similar to a spirit level, moving downward as the eye replaces the gas volume with natural aqueous fluid. Desk-based work can resume once gas volume decreases significantly and head positioning is discontinued by the surgeon.

Months 2–12: Final visual acuity recovery occurs slowly over 6 to 12 months, particularly in cases where the macula was detached prior to repair. Patients with phakic eyes (natural crystal lens intact) will experience progression of nuclear sclerotic cataracts over 6 to 24 months, frequently requiring standard cataract surgery to achieve final visual potential.

12. Risks, Side Effects, and Complications

While modern vitreoretinal surgery exhibits high safety profiles, procedure-related risks exist. Complications are stratified in the risk severity matrix below:

Severity LevelPotential ComplicationClinical PresentationManagement Protocol
Common / ExpectedPost-Vitrectomy CataractGradual clouding of vision, loss of color contrast over 6–24 monthsElective cataract surgery with intraocular lens implantation
Common / TransientElevated Intraocular PressureOcular aching, headache, corneal haziness in first 48 hoursTopical or systemic pressure-lowering medications
Uncommon (5%–10%)Recurrent Retinal DetachmentReturn of light flashes, shadow/curtain in peripheral visionSecondary vitreoretinal surgery with PVR membrane peeling
Uncommon (2%–5%)Vitreous / Subretinal HemorrhageSudden increase in floaters or darkening of visual fieldObservation, elevation of head; secondary vitrectomy if non-clearing
Rare / Serious (<0.1%)Endophthalmitis (Internal Infection)Rapidly worsening pain, severe visual drop, hypopyon (pus in front chamber)Urgent intravitreal antibiotic injection or emergency re-operation
Rare / Serious (<0.5%)Suprachoroidal HemorrhageSevere intraoperative or sudden acute pain and vision lossImmediate surgical stabilization, systemic steroids, pressure control

The primary cause of surgical failure is Proliferative Vitreoretinopathy (PVR), a cellular scar process where retinal pigment epithelial and glial cells proliferate on the surface of the retina, creating contractile sheets that pull the retina off the back wall again. Large-scale cohort studies demonstrate that PVR occurs in 5% to 10% of primary repairs, requiring secondary surgical removal of scar tissue (Jackson et al., British Journal of Ophthalmology, 2013).

13. Lifestyle and Behavioural Considerations

Adherence to post-operative instructions directly impacts surgical success rates. Patients receiving gas tamponade must strictly avoid high-altitude travel and air transportation until total bubble reabsorption is clinically confirmed by an ophthalmologist. When seeking medical care or emergency therapy, patients must notify all healthcare providers that they have an expandable gas bubble in their eye to prevent administration of inhaled nitrous oxide gas during general anesthesia or dental procedures.

Physical exertion guidelines restrict heavy lifting (>10–15 lbs), bending over so the head falls below the waist, and strenuous aerobic activity for 4 to 6 weeks post-operatively to avoid sudden fluctuations in intraocular pressure and mechanical jarring. Eye protection, such as polycarbonate safety glasses, is recommended during sports or physical activities once fully recovered.

14. How Outcomes Are Measured

Clinical success in retinal detachment repair is evaluated across two distinct parameters: anatomical success (single-operation primary reattachment rate) and functional success (final visual acuity recovery).

Anatomical reattachment is confirmed via slit-lamp biomicroscopy and optical coherence tomography (OCT) demonstrating total resolution of subretinal fluid and flat apposition of the retina against the underlying retinal pigment epithelium. Large registry data indicate primary single-operation anatomical success rates between 85% and 92%, with ultimate reattachment rates exceeding 98% following secondary interventions if required (Primary Retinal Detachment Outcomes [PRO] Study Group, 2013).

Functional visual recovery depends heavily on preoperative macular status. For macula-on detachments, over 90% of patients maintain pre-detachment visual acuity (20/40 or better). For macula-off detachments, visual recovery is variable; while anatomical reattachment is achieved in most cases, microscopic damage to central photoreceptor outer segments often leaves baseline micro-distortion (metamorphopsia) or reduced overall letter acuity (Hillier et al., PIVOT Trial, 2019).

15. Recent Advances and Current Standard of Care

Over the past 15 years, vitreoretinal surgery has transitioned from 20-gauge large-incision vitrectomy requiring conjunctival peritomy and scleral suturing to ultra-high-speed 25-gauge and 27-gauge micro-incision vitrectomy systems (MIVS). Modern cutters operate at rates up to 20,000 cuts per minute with dual-pneumatic blades, significantly reducing vitreous traction on surrounding healthy retina and lowering post-operative ocular inflammation.

Advanced intraoperative visualization systems, including heads-up 3D digital visualization displays and intraoperative Optical Coherence Tomography (iOCT), now allow vitreoretinal surgeons to visualize sub-micron tissue layers and subtle epiretinal membranes in real-time during surgery. Additionally, ongoing clinical trials are investigating long-acting liquid fluorocarbon derivatives and bio-absorbable retinal scaffolds to reduce or eliminate strict face-down positioning requirements in the future.

16. Common Myths and Misconceptions

Myth: Retinal detachment repair can be performed using non-invasive outer eye drop medications.
Reality: Drops cannot repair physical retinal tears or evacuate fluid from under the retina. Physical microsurgical intervention (PPV, SB, or PR) is mandatory to repair rhegmatogenous detachment (AAO PPP, 2020).

Myth: Laser eye surgery (such as LASIK) causes retinal detachment.
Reality: Excimer laser corneal surgery does not cause retinal tears. However, patients who qualify for LASIK often have underlying high myopia (nearsightedness), an independent structural risk factor for retinal detachment due to an elongated eyeball.

Myth: Patients can safely fly on commercial airplanes immediately after vitreoretinal surgery.
Reality: Flying with an intraocular gas bubble is strictly dangerous. Decreased cabin pressure causes the intraocular gas bubble to expand rapidly, elevating eye pressure to catastrophic levels that cut off blood flow to the optic nerve, causing permanent blindness.

Myth: Visual acuity returns to normal immediately after the retina is surgically reattached.
Reality: Visual recovery is a slow process taking 3 to 12 months. The presence of an intraocular gas bubble blocks vision initially, and photoreceptor cells require months to recover micro-structural function.

Myth: Retinal detachment surgery is extremely painful.
Reality: Modern retrobulbar anesthesia and micro-incision techniques ensure the surgical procedure is entirely painless. Post-operative discomfort is typically mild to moderate and easily controlled with simple analgesics.

Myth: A retinal detachment in one eye means the other eye will definitely detach too.
Reality: While having a retinal detachment increases the statistical risk of a tear in the fellow eye to approximately 10%–15%, routine dilated screening examinations allow clinicians to detect and laser pre-existing peripheral breaks before detachment occurs.

17. Frequently Asked Questions

What is the difference between a retinal tear and a retinal detachment?

A retinal tear is a physical break or hole in the retinal tissue caused by vitreous traction, but fluid has not yet accumulated behind the retina. A retinal detachment occurs when fluid passes through that tear into the space beneath the retina, separating it from the underlying blood supply wall.

How long must I maintain face-down positioning after retinal detachment surgery?

Head positioning duration depends on the size of the break and the gas or oil tamponade used. Surgeons typically prescribe specific head positioning (such as face-down) for 3 to 14 days post-operatively, for 16 to 20 hours per day, to keep the gas bubble pressed firmly against the tear.

Can I travel by car or train with a gas bubble in my eye?

Ground travel by car or train is generally safe, provided travel does not involve significant altitude changes (such as driving through high mountain passes above 2,000 feet altitude). Expanding altitude pressure changes can cause dangerous intraocular pressure spikes.

When can I return to work after retinal detachment repair?

Return-to-work timing depends on job requirements and vision status. Most patients with sedentary desk jobs resume work within 2 to 3 weeks once positioning requirements end. Physical labor or environments with dust and heavy lifting require 4 to 6 weeks of recovery.

Will I develop a cataract after vitrectomy surgery?

If you have your natural crystalline lens (phakic), cataract development is extremely common after vitrectomy surgery. Studies show over 80% of phakic patients develop nuclear sclerotic cataracts within two years, which can be safely corrected with routine outpatient cataract surgery.

Why is silicone oil used instead of gas in some retinal detachment surgeries?

Silicone oil provides long-term, stable tamponade for complex detachments, such as severe proliferative vitreoretinopathy (PVR) or giant retinal tears. Unlike gas, silicone oil does not reabsorb naturally and must be removed during a minor secondary surgical procedure months later.

What are photopsias and floaters, and why do they happen?

Photopsias (light flashes) occur when the gel-like vitreous tugs mechanically on the sensitive nerve tissue of the retina. Floaters are dark spots or strands caused by microscopic clumps of vitreous gel or tiny drops of blood casting shadows on the retina.

What should I do if I notice a sudden dark shadow in my vision?

A sudden dark curtain or shadow sweeping across your visual field is a medical emergency indicating potential retinal detachment. You must seek evaluation by an ophthalmologist or vitreoretinal specialist immediately, ideally within 24 hours.

Can a retinal detachment recur after successful surgery?

Yes, retinal detachment can recur in 5% to 15% of cases, most commonly due to proliferative vitreoretinopathy (PVR)—a scarring process that pulls on the retina—or the formation of new retinal tears. Recurrent detachments require secondary vitreoretinal surgery.

Is general anesthesia required for retinal detachment repair?

Most retinal detachment repairs in adults are performed using local anesthesia (retrobulbar block) combined with intravenous sedation. General anesthesia is reserved for children, highly anxious patients, complex prolonged reconstructions, or patients unable to lie still.

How does nearsightedness (myopia) affect my risk of retinal detachment?

High myopia (typically optical prescription greater than -6.00 diopters) causes elongation of the eyeball wall. This stretches the retina thinner, increasing the risk of peripheral retinal tears and subsequent detachment by up to ten times compared to non-myopic eyes.

Can I watch television or read with my good eye during recovery?

Yes, limited reading and watching television using the non-operated eye is generally permitted, provided you maintain your prescribed head positioning. Excessive side-to-side eye tracking should be minimized during early recovery to prevent ocular movement.

Booking With DIVINHEAL

Get a free consultation to understand your treatment options

Cost Calculator

I know my treatment — show me cost from 3 hospitals

Plan My Journey

Tell us your condition and budget — our AI matches the right destination, hospital and doctor and visa pathway

Healthcare Services

Our Speciality and Treatments

Doctors

Meet Our Medical Specialists

View All
Aditi Dixit

Sr. Consultant – Women Imaging

Aditi Dixit

MBBS, MD

Haryana

Amit Jassal

Sr. Consultant - Anaesthesia

Amit Jassal

MBBS, MD

Haryana

Anjana Kharbanda

Sr. Consultant - Emergency

Anjana Kharbanda

MBBS, MD

India

Dr. Abhinandan Mukhopadhyay

Sr. Consultant - Urology & Kidney Transplant Program (Unit I)

Dr. Abhinandan Mukhopadhyay

MBBS, MD

India

Dr. Ajit Singh Baghela

Consultant

Dr. Ajit Singh Baghela

MBBS, MD

Gurugram

Aditi Dixit

Sr. Consultant – Women Imaging

Aditi Dixit

MBBS, MD

Haryana

Amit Jassal

Sr. Consultant - Anaesthesia

Amit Jassal

MBBS, MD

Haryana

Anjana Kharbanda

Sr. Consultant - Emergency

Anjana Kharbanda

MBBS, MD

India

Dr. Abhinandan Mukhopadhyay

Sr. Consultant - Urology & Kidney Transplant Program (Unit I)

Dr. Abhinandan Mukhopadhyay

MBBS, MD

India

Dr. Ajit Singh Baghela

Consultant

Dr. Ajit Singh Baghela

MBBS, MD

Gurugram

Hospitals

NABH & JCI Accredited Hospitals in India,Turkey, Thailand & UAE.

View All
Artemis Hospital

Artemis Hospital

Sector 51, Gurugram, Haryana, India

Lokmanya Hospitals

Lokmanya Hospitals

Not Specified

White Lotus Hospital

White Lotus Hospital

766, SFS 3145, SFS Road, 7th Sector, HSR Layout, Bengaluru, Karnataka 560102, India

Institute of Brain and Spine (IBS Hospital)

Institute of Brain and Spine (IBS Hospital)

Not Specified

How DivinHeal Helps

We simplify your medical journey by providing comprehensive support and access to world-class healthcare.

Expert Specialist Matching

Connecting you with the world's top-rated medical experts.

FAQ

Everything you
need to know today

Browse through these common inquiries to better understand our patient-focused medical platform.

Yes, we work with a variety of insurance providers. Contact our team to verify your coverage.

Yes, we provide secure online consultations with experienced specialists.

Our care coordinators help match you with the most suitable specialist.

Absolutely. Your medical information is protected according to healthcare privacy standards.

Look at six things: accreditation (JCI or NABH), specialty depth, doctor credentials and experience, procedure-specific success rates, international patient support, and technology. DivinHeal's AI-driven matching evaluates every hospital in our accredited partner network on these dimensions and shortlists the best-fit options for your condition, budget, and country.

JCI (Joint Commission International) is the US-based global gold standard for hospital quality, recognised worldwide. NABH is India's national accreditation — accredited by ISQua, the same body that accredits JCI. Both signal independently verified safety and quality. Most of India's leading hospitals hold both.

Yes. All three welcome international patients through structured medical visa programs. India is the most established, treating patients from Africa, the Middle East, and South Asia at 60–80% lower cost. Thailand leads in cosmetic and dental care. The UAE is emerging in oncology and reproductive medicine.

Most patients save 50–80% on treatment costs. Heart bypass costs US $7,000–9,000 in India compared to $70,000–150,000 in the US. IVF costs $3,000–4,500 compared to $12,000–20,000 in the UK. Even after flights, visa, and accommodation, total savings remain 60–70%.

DivinHeal manages your entire non-medical journey: visa invitation letters, medical visa guidance, doctor appointments, teleconsultations, airport pickup, hospital-vetted accommodation for you and your attendant, language interpreters, local transport, cuisine preferences, and post-treatment follow-up — one dedicated coordinator from first enquiry to final follow-up.

You need a valid passport (6+ months validity), a medical visa (M-Visa for India — DivinHeal provides the hospital invitation letter), return flight tickets, recent medical reports and a doctor's referral, current prescription list, and proof of financial means. Any accompanying attendant needs their own passport and MX-Visa.

Still have more questions?

Book a call with our friendly team to learn how DivineHeal simplifies your healthcare journey.